SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lazaros I. Sakkas, Dimitrios P. Bogdanos, Christina Katsiari, Chris D. Platsoucas, Anti-citrullinated peptides as autoantigens in rheumatoid arthritis—relevance to treatment, Autoimmunity Reviews, 2014, 13, 11, 1114

    CrossRef

  2. 2
    Emilio Besada, Is There an Interactive Effect of Immunoglobulin Levels and CD4+ Cell Counts During Rituximab Treatment? Comment on the Article by Mélet et al, Arthritis & Rheumatology, 2014, 66, 4
  3. 3
    D. Mulleman, G. Thibault, Reply, Arthritis & Rheumatology, 2014, 66, 4
  4. 4
    Sung Hae Chang, Ji Ae Yang, Sang Jin Lee, Jun Won Park, Kichul Shin, Eun Bong Lee, Yeong Wook Song, Eun Young Lee, Treatment with Rituximab in a Patient with Refractory Felty Syndrome and Low Rheumatoid Arthritis Disease Activity: A Case Report, Journal of Rheumatic Diseases, 2014, 21, 1, 35

    CrossRef

  5. 5
    Delnia Arshadi, Behrouz Nikbin, Yadollah Shakiba, Amir Kiani, Ahmad Reza Jamshidi, Mohammad Taher Boroushaki, Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: Association with gender, disease activity and anti-CCP antibody, International Immunopharmacology, 2013, 17, 3, 763

    CrossRef

  6. 6
    J. Mélet, D. Mulleman, P. Goupille, B. Ribourtout, H. Watier, G. Thibault, Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical Response, Arthritis & Rheumatism, 2013, 65, 11